Skip to content
WeighLab

REMEVi vs NiceRx

Compare the prices, treatment options and tradeoffs that matter before you choose a GLP-1 program.

By The WeighLab Bench. Provider verification dates appear below.

REMEVi

Provider comparison

Spanish- and English-speaking shoppers who want LegitScript-certified compounded GLP-1 care in their own language.

Semaglutide / month
$199 per 4 weeksMonth-to-month, same at every dose; $159 per 4 weeks on a 24-week plan paid up front, compounded
Tirzepatide / month
$269 per 4 weeksMonth-to-month, same at every dose; $225 per 4 weeks on a 24-week plan paid up front, compounded
Index 82/100 · Grade B−Checked October 2026

NiceRx

Provider comparison

Cost-first shoppers who want a clearly disclosed standing month-to-month rate rather than a prepay-gated one.

Semaglutide / month
$149 per 4 weeksAll doses, compounded
Tirzepatide / month
$249 per 4 weeksAll doses, compounded
Index 82/100 · Grade B−Checked October 2026

We may earn a commission if you sign up through a provider link, at no extra cost to you. Compensation does not change scores. How we earn money.

The comparison in brief

Both score 82/100 on the Cost-Efficiency Index. There is no score winner; compare the treatment you need, billing terms and state availability.

Check the difference in state access

REMEVi
49 states + DC
NiceRx
46 states

The better fit depends on what is included in your quote. A lower advertised price can require prepayment, apply to a starting dose or leave out a separate fee.

How the comparison is scored

Costs & coverage

Published prices with their terms intact. Annual estimates account for billing frequency and known fixed required fees; they are not a treatment quote.

REMEVi

NiceRx

Semaglutide / month
REMEVi: $199 per 4 weeksMonth-to-month, same at every dose; $159 per 4 weeks on a 24-week plan paid up front, compounded
NiceRx: $149 per 4 weeksAll doses, compounded
Tirzepatide / month
REMEVi: $269 per 4 weeksMonth-to-month, same at every dose; $225 per 4 weeks on a 24-week plan paid up front, compounded
NiceRx: $249 per 4 weeksAll doses, compounded
Semaglutide / year (modeled)
REMEVi: $2,58713 charges
NiceRx: $1,93713 charges
Tirzepatide / year (modeled)
REMEVi: $3,49713 charges
NiceRx: $3,23713 charges
State availability
REMEVi: 49 states + DC
NiceRx: 46 states
Oral / sublingual option listed
REMEVi: Yes
NiceRx: Not listed
Brand-name access listed
REMEVi: Not confirmed
NiceRx: Not confirmed
Provider facts checked
REMEVi: October 2026
NiceRx: October 2026

Comparing different billing plans? See what a GLP-1 monthly price can leave out, or calculate the monthly cost.

Which program fits your priorities?

The strengths and limitations behind each provider's score. Read the full review before deciding.

REMEVi

Spanish- and English-speaking shoppers who want LegitScript-certified compounded GLP-1 care in their own language.

Reasons to consider it

  • A genuinely flat rate: 'the same price at every dose', stated as such, with no dose upcharge and no introductory rate to step off
  • Longer terms are published openly rather than used as a teaser: semaglutide falls to $169 every 4 weeks on a 12-week plan and $159 on a 24-week plan
  • A daily oral semaglutide tablet is offered alongside the injection

What to weigh up

  • Billing runs every 4 weeks, so a year of month-to-month care is 13 charges, and the lowest $159 rate needs 24 weeks paid up front
  • No FDA-approved brand-name pathway — the Wegovy and Ozempic pages are comparison content, not products
  • Compounded semaglutide and tirzepatide are not FDA-approved finished products

NiceRx

Cost-first shoppers who want a clearly disclosed standing month-to-month rate rather than a prepay-gated one.

Reasons to consider it

  • Public prices for each plan length
  • Provider review, medication and delivery included
  • Names Nice Health medical groups and six pharmacy partners

What to weigh up

  • Four-week billing means 13 charges over 52 weeks
  • Lower headline averages require 12-, 24- or 48-week prepayment
  • Generic pricing-page monthly language conflicts with the explicit product billing intervals

Explore the six scoring factors

Scores run from 0 to 100. A higher factor score reflects our published value criteria; it is not a clinical endorsement.

REMEViNiceRx
Normalized Cost/Month
REMEVi:
74/100
NiceRx:
85/100
Price Transparency
REMEVi:
94/100
NiceRx:
97/100
Nationwide Access
REMEVi:
86/100
NiceRx:
78/100
Formulation Options
REMEVi:
77/100
NiceRx:
66/100
Clinical Oversight
REMEVi:
87/100
NiceRx:
91/100
Contract Flexibility
REMEVi:
69/100
NiceRx:
67/100

Before you sign up

  • Confirm your totalAsk about dose changes, membership, labs, shipping and cancellation terms.
  • Check treatment accessState coverage and medical eligibility can differ by medication and formulation.
  • Understand the medicationCompare compounded and brand-name options. Compounded drugs are not FDA-approved.

Keep comparing

More provider matchups
Choose a different comparison

Provider information reflects public disclosures at the verification dates shown. Prices and availability change; confirm current terms before paying. This comparison is for information, not medical advice. A licensed clinician determines whether treatment is appropriate.